Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Find out what happens when you delay retirement planning and the risks involved. Make informed decisions for a secure retirement.
20,380 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Investors are shifting from FXI to a South Korea-focused ETF to capture the AI hardware boom, citing lower costs and ...
Ethereum fell under $1.8K as a broader crypto pullback tested key support. Analysts warn of a delicate setup, with po...
Prime Day results defy pessimism as consumers keep shopping online and Amazon’s cloud growth supports the stock. The ...
A surge in investor interest centers on SPCX as SpaceX expands its orbit into launches, satellite networks, and AI ve...
Robinhood shares surged after several brokerages initiated coverage with Buy ratings as the broader crypto rebound li...
Bitcoin remains perched above the $62,000 level as traders rotate back into risk assets. Altcoins like HYPE and ADA l...
As Brazil begins a measured rate-cut cycle, EWZ may emerge as a tactical edge in 2026. A slower Fed and a stronger BR...
As AI tools ride into homebuilding, a new asset is emerging: institutional knowledge. Builders that centralize data a...
MicroStrategy’s stock remains tightly tied to Bitcoin, making the crypto’s direction a key determinant of the company...
AI-driven models flag XRP as the most likely to post the biggest gains in the second half of 2026, even as Bitcoin an...
Meta quietly positions itself as the strongest mega-cap alternative this summer, leveraging ad momentum and a new AI ...